SWP
PDLI

Strategic Wealth Partners’s PDL BioPharma, Inc. PDLI Stock Holding History

Strategic Wealth Partners’s Portfolio PDLI Stock Details PDLI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-68,477
Closed -$216K – 182
2020
Q3 		$216K Hold
68,477
– – 0.11% 142
2020
Q2 		$199K Buy
+68,477
New +$217K 0.1% 130
2019
Q2 		– Sell
-13,572
Closed -$51K – 849
2019
Q1 		$51K Hold
13,572
– – 0.02% 239
2018
Q4 		$44K Buy
+13,572
New +$37.3K 0.02% 244

Other funds holding PDLI

SPC
Silver Point Capital Greenwich, Connecticut $1.1B AUM 20.71% 1-Year Est. Return
PWAM
Park West Asset Management San Francisco, California $1.47B AUM 86.42% 1-Year Est. Return
GCIA
Gabelli & Co Investment Advisers Rye, New York $688M AUM 63.39% 1-Year Est. Return
JC
JBF Capital Aspen, Colorado $764M AUM 24.26% 1-Year Est. Return
GF
Gabelli Funds Rye, New York $15.7B AUM 36.4% 1-Year Est. Return
CCM
Context Capital Management Lajolla, California $5.15B AUM 1.28% 1-Year Est. Return
WG
Winton Group London, United Kingdom $3.09B AUM 40.4% 1-Year Est. Return
California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $177B AUM 39.86% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $114B AUM 41.71% 1-Year Est. Return
HW
Hancock Whitney Gulfport, Mississippi $6B AUM 34.57% 1-Year Est. Return

Strategic Wealth Partners's PDLI Position: Q4 2020 in Review

Strategic Wealth Partners sold out of PDL BioPharma, Inc. (PDLI) in Q4 2020, closing a stake of 68,477 shares — an estimated $216K sold.

Strategic Wealth Partners first reported a position in PDLI in Q4 2018 and held it in 4 quarters. The position peaked at $216K in Q3 2020. 33 funds tracked by Wall St. Rank hold PDLI as of Q4 2020.

  • Strategic Wealth Partners reported no remaining PDL BioPharma, Inc. position as of Q4 2020 after selling out during the quarter.
  • Strategic Wealth Partners sold 68,477 PDL BioPharma, Inc. shares in Q4 2020, an estimated $216K.
  • Strategic Wealth Partners first reported a position in PDL BioPharma, Inc. in Q4 2018 and held it in 4 quarters.
  • Strategic Wealth Partners's PDL BioPharma, Inc. position peaked at $216K in Q3 2020.
  • 33 funds tracked by Wall St. Rank held PDL BioPharma, Inc. as of Q4 2020.

Based on Strategic Wealth Partners's 13F filing for Q4 2020, filed 18 Feb 2021.